Elbit Imaging Ltd (EMITF) 3.14 $EMITF
Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited
PR Newswire - Sun Sep 14, 3:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 and September 8, 2014 (the "Company's Previous Reports" , that it was informed by InSightec Ltd. ("InSightec" , of the closing of investment of US$ 12.5 million by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited (jointly: the "Chinese Group" .In the framework of the present investment round in InSightec, the Chinese Group has exercised the right granted thereto in the investment round documents (as specified in the Company's Previous Reports) and has acquired a total of 6,444,404 Series D preferred shares of InSightec, which represent approx. 5% of the share capital of InSightec on a fully diluted basis, in consideration for a total payment of U.S. $12.5 million. Upon the closing of the transaction, the, Elbit Medical's holding in InSightec is 37.6% (33.3% on a fully diluted basis).
Elbit Imaging Ltd. Announces Compliance With Nasdaq Minimum Bid Price
PR Newswire - Wed Sep 10, 2:46AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that the Nasdaq Global Select Market ("Nasdaq" has notified the Company it has regained compliance with Listing Rule 5450(a)(1) which requires that listed stocks maintain a closing bid price in excess of $1.00 per share.
Elbit Imaging ltd. Announces an Execution of an Amendment to the Investment Agreement in InSightec and Extension of the Investment Period
PR Newswire - Mon Sep 08, 2:42AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 that it was informed by InSightec Ltd. ("InSightec" , that an agreement for amendment of the investment agreement of June 26, 2014 has been signed (the "Amendment to the Investment Agreement" and the "Investment Agreement", respectively), in the framework of which, the period granted to Elbit Medical Technologies Ltd. and to the existing shareholders of InSightec (the "Existing Shareholders" to notify InSightec if they intend to purchase the shares of InSightec (as specified in the Company's report dated June 29, 2014), was extended until November 30, 2014.
Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
PR Newswire - Tue Sep 02, 6:51AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today following the Company's announcement dated August 19, 2014 that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 85% on a fully diluted basis, announced that on September 1, 2014 Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and vast majority of Gamida Cell's shareholders (including Elbit Medical), completed the execution of the Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis).
Elbit Imaging Ltd. Announces Effectiveness of Reverse Share Split
PR Newswire - Fri Aug 22, 8:30AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that the previously announced one-for-twenty reverse split of the Company's ordinary shares became effective at 5:00 p.m. (New York time) on Thursday, August 21, 2014 and that the shares commenced trading on a reverse split-adjusted basis upon the open of trading on the NASDAQ Global Select Market on Friday, August 22, 2014. With respect to the Tel Aviv Stock Exchange, the shares will commence trading on a reverse split-adjusted basis upon the open of trading on Sunday, August 24, 2014.
Real Estate Management and Development Equities Update -- CBRE, E-House China Holdings, Realogy Holdings, Forest City Enterprises, and Elbit Imaging
PR Newswire - Tue Aug 19, 8:20AM CDT
On Monday, August 18, 2014, the NASDAQ Composite ended at 4,508.31, up 0.97%, the Dow Jones Industrial Average finished the session at 16,838.74, up 1.06% and the S&P 500 closed at 1,971.74, up 0.85%. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day 1.08% higher at 307.11, while the index has declined 0.49% in the previous one month. Investor-Edge has initiated coverage on the following equities: CBRE Group Inc. (NYSE: CBG), E-House China Holdings Ltd (NYSE: EJ), Realogy Holdings Corp. (NYSE: RLGY), Forest City Enterprises Inc. (NYSE: FCE-A), and Elbit Imaging Ltd (NASDAQ: EMITF). Free research on these five companies can be accessed at:
Why Novartis (NVS) Stock Is Gaining Today
at The Street - Tue Aug 19, 7:28AM CDT
The Swiss drugmaker agreed to take a 15% stake in Gamida Cell, an Israeli developer of stem cell therapies, in a deal that could reach over $600 million.
Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 1:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis).
Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 12:55AM CDT
Gamida Cell, a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG ("Novartis" . According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable for a limited period of time following achievement of certain milestones connected to the development of NiCord®, anticipated to be met during 2015. Completion of the transaction is subject to customary closing conditions.
Elbit Imaging Ltd. Announces Results of Annual Meeting and Reverse Share Split Confirmation
PR Newswire - Thu Aug 14, 5:44AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that at its annual general meeting of shareholders held today, the Company's shareholders approved all of the proposals on the agenda, including authorization to effect a reverse share split.
Elbit Imaging declares further updates to its annual general meeting proposals
M2 - Fri Aug 08, 3:16AM CDT
Elbit Imaging Ltd (NASDAQ GSM:EMITF), the holding company of subsidiaries engaged in diverse industries, on Thursday provided more updates about proposals 4 and 6 on the agenda of its annual general meeting of shareholders, to be held on 14 August 2014.
Elbit Imaging Ltd. Announces Additional Updates to Annual General Meeting Proposal
PR Newswire - Fri Aug 08, 2:55AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today further to the Company's announcements dated August 5, 2014 and August 7, 2014, additional updates regarding a proposal on the agenda of its annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting" .
Elbit Imaging Ltd. Announces Updates to Two Annual General Meeting Proposals
PR Newswire - Tue Aug 05, 9:01AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today updates regarding two proposals on the agenda of it annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting" .
Elbit Imaging Ltd. Announces Closing of Settlement Agreement With Bank Leumi
PR Newswire - Wed Jul 23, 6:15AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company" announced today, following its announcement dated July 1, 2014 (the "Previous Announcement" , that following the Court's approval the transactions contemplated by the settlement between the Company and Bank Leumi Le Israel B.M. ("Bank Leumi" have been consummated. Under the settlement, Bank Leumi received ownership of all marketable securities held in the Company's accounts at Bank Leumi having a fair value of approximately NIS 8.7 million (based on their quoted market price). The Company's net debt (after offset of the aforementioned marketable securities) to Bank Leumi in the amount of approximately NIS 38 million was cancelled in exchange for 7,404,119 ordinary shares, NIS 6,507,666 aggregate principal amount of Series G notes and NIS 3,166,678 aggregate principal amount of Series H notes of the Company. The balance of 1,686,003 ordinary shares, NIS 1,481,870 aggregate principal amount of Series G notes and NIS 721,089 aggregate principal amount of Series H notes of the Company retained in trust will be cancelled. As described in the Previous Announcement, the Settlement also includes a mutual waiver of claims by the Company and Bank Leumi.
The Company's Subsidiary, Plaza Centers N.V., Announces Effectivness Of Debt Restructuring Plan
PR Newswire - Mon Jul 21, 2:06PM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today further to the Company's announcements made on March 27, 2014 and June 26, 2014, that its subsidiary, Plaza Centers N.V. (LSE: PLAZ, WSE: PLZ/PLAZACNTR) ("Plaza" , has announced that following the Dutch Court (the "Court" approving Plaza's restructuring plan (the "Plan" on July 9, 2014, Plaza has received confirmation that the decision of the Court has become irrevocable and, as a result, the date of July 18, 2014 is the "Effective Date" as defined in the Plan on which the Plan becomes binding and effective. As a consequence of the confirmation decision becoming final, Plaza's suspension of payment proceedings, which commenced on November 18, 2013, has today come to an end and Plaza has successfully emerged from the reorganization proceedings. Accordingly, the administrator appointed by the Court to manage the affairs of Plaza alongside its existing management is no longer in office and Plaza's management has resumed full control of the business.
Elbit Imaging Ltd. Announces Election of New Board Members of Plaza Centers
PR Newswire - Sun Jul 13, 8:38AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company" announced today, that Plaza Centers N.V. ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds directly and indirectly approximately 62.5% of the outstanding shares, announced following its Annual General Meeting held on July 8, 2014, that the following individuals shall be appointed to its board of directors with immediate effect: Mr. Ron Hadassi, Mr. David Dekel, Mr. Shlomi Kelsi, Mr. Yoav Kfir, Mr. Nadav Livni. The newly appointed directors of Plaza will join Messrs Marco Habib Wichers and Sarig Shalhav to form a board of directors comprising seven members.
Elbit Imaging Ltd. Calls 2014 Annual Shareholders Meeting
PR Newswire - Thu Jul 10, 4:29PM CDT
Elbit Imaging Ltd. (NASDAQ: EMITF)
Elbit Imaging Ltd. Announces: Dutch Court Approves Debt Restructuring Plan of Plaza Centers
PR Newswire - Thu Jul 10, 11:31AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company" announced today, following its announcement dated June 26, 2014, that Plaza Centers N.V. ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds directly and indirectly approximately 62.5% of the outstanding shares, and following the confirmation hearing held yesterday, that the Dutch Court has confirmed Plaza's restructuring plan (the "Plan" . This follows Plaza receiving approval from 92% of creditors voting in favor of the Plan.
Elbit Imaging's subsidiary signs sale agreement of PPHE Hotel Group's shares for USD10.2m
M2 - Mon Jul 07, 7:29AM CDT
Elbit Imaging Ltd (TASE:EMITF) (NASDAQ:EMITF) revealed on Friday that its wholly owned subsidiary signed into a transaction for the sale of 1.7m shares of PPHE Hotel Group (LSE
PH), for a net consideration of USD10.2m.
Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited
PR Newswire - Sun Sep 14, 3:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 and September 8, 2014 (the "Company's Previous Reports" , that it was informed by InSightec Ltd. ("InSightec" , of the closing of investment of US$ 12.5 million by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited (jointly: the "Chinese Group" .In the framework of the present investment round in InSightec, the Chinese Group has exercised the right granted thereto in the investment round documents (as specified in the Company's Previous Reports) and has acquired a total of 6,444,404 Series D preferred shares of InSightec, which represent approx. 5% of the share capital of InSightec on a fully diluted basis, in consideration for a total payment of U.S. $12.5 million. Upon the closing of the transaction, the, Elbit Medical's holding in InSightec is 37.6% (33.3% on a fully diluted basis). Elbit Imaging Ltd. Announces Compliance With Nasdaq Minimum Bid Price
PR Newswire - Wed Sep 10, 2:46AM CDT
Elbit Imaging Ltd. ("EI" or "Company"
(NASDAQ GSM: EMITF) announced today that the Nasdaq Global Select Market ("Nasdaq" has notified the Company it has regained compliance with Listing Rule 5450(a)(1) which requires that listed stocks maintain a closing bid price in excess of $1.00 per share. Elbit Imaging ltd. Announces an Execution of an Amendment to the Investment Agreement in InSightec and Extension of the Investment Period
PR Newswire - Mon Sep 08, 2:42AM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 that it was informed by InSightec Ltd. ("InSightec" , that an agreement for amendment of the investment agreement of June 26, 2014 has been signed (the "Amendment to the Investment Agreement" and the "Investment Agreement", respectively), in the framework of which, the period granted to Elbit Medical Technologies Ltd. and to the existing shareholders of InSightec (the "Existing Shareholders" to notify InSightec if they intend to purchase the shares of InSightec (as specified in the Company's report dated June 29, 2014), was extended until November 30, 2014. Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
PR Newswire - Tue Sep 02, 6:51AM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today following the Company's announcement dated August 19, 2014 that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 85% on a fully diluted basis, announced that on September 1, 2014 Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and vast majority of Gamida Cell's shareholders (including Elbit Medical), completed the execution of the Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis). Elbit Imaging Ltd. Announces Effectiveness of Reverse Share Split
PR Newswire - Fri Aug 22, 8:30AM CDT
Elbit Imaging Ltd. ("EI" or "Company"
(NASDAQ GSM: EMITF) announced today that the previously announced one-for-twenty reverse split of the Company's ordinary shares became effective at 5:00 p.m. (New York time) on Thursday, August 21, 2014 and that the shares commenced trading on a reverse split-adjusted basis upon the open of trading on the NASDAQ Global Select Market on Friday, August 22, 2014. With respect to the Tel Aviv Stock Exchange, the shares will commence trading on a reverse split-adjusted basis upon the open of trading on Sunday, August 24, 2014. Real Estate Management and Development Equities Update -- CBRE, E-House China Holdings, Realogy Holdings, Forest City Enterprises, and Elbit Imaging
PR Newswire - Tue Aug 19, 8:20AM CDT
On Monday, August 18, 2014, the NASDAQ Composite ended at 4,508.31, up 0.97%, the Dow Jones Industrial Average finished the session at 16,838.74, up 1.06% and the S&P 500 closed at 1,971.74, up 0.85%. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day 1.08% higher at 307.11, while the index has declined 0.49% in the previous one month. Investor-Edge has initiated coverage on the following equities: CBRE Group Inc. (NYSE: CBG), E-House China Holdings Ltd (NYSE: EJ), Realogy Holdings Corp. (NYSE: RLGY), Forest City Enterprises Inc. (NYSE: FCE-A), and Elbit Imaging Ltd (NASDAQ: EMITF). Free research on these five companies can be accessed at:
Why Novartis (NVS) Stock Is Gaining Today
at The Street - Tue Aug 19, 7:28AM CDT
The Swiss drugmaker agreed to take a 15% stake in Gamida Cell, an Israeli developer of stem cell therapies, in a deal that could reach over $600 million.
Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 1:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis). Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 12:55AM CDT
Gamida Cell, a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG ("Novartis"
. According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable for a limited period of time following achievement of certain milestones connected to the development of NiCord®, anticipated to be met during 2015. Completion of the transaction is subject to customary closing conditions. Elbit Imaging Ltd. Announces Results of Annual Meeting and Reverse Share Split Confirmation
PR Newswire - Thu Aug 14, 5:44AM CDT
Elbit Imaging Ltd. ("EI" or "Company"
(NASDAQ GSM: EMITF) announced today that at its annual general meeting of shareholders held today, the Company's shareholders approved all of the proposals on the agenda, including authorization to effect a reverse share split. Elbit Imaging declares further updates to its annual general meeting proposals
M2 - Fri Aug 08, 3:16AM CDT
Elbit Imaging Ltd (NASDAQ GSM:EMITF), the holding company of subsidiaries engaged in diverse industries, on Thursday provided more updates about proposals 4 and 6 on the agenda of its annual general meeting of shareholders, to be held on 14 August 2014.
Elbit Imaging Ltd. Announces Additional Updates to Annual General Meeting Proposal
PR Newswire - Fri Aug 08, 2:55AM CDT
Elbit Imaging Ltd. ("EI" or "Company"
(NASDAQ GSM: EMITF) announced today further to the Company's announcements dated August 5, 2014 and August 7, 2014, additional updates regarding a proposal on the agenda of its annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting" . Elbit Imaging Ltd. Announces Updates to Two Annual General Meeting Proposals
PR Newswire - Tue Aug 05, 9:01AM CDT
Elbit Imaging Ltd. ("EI" or "Company"
(NASDAQ GSM: EMITF) announced today updates regarding two proposals on the agenda of it annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting" . Elbit Imaging Ltd. Announces Closing of Settlement Agreement With Bank Leumi
PR Newswire - Wed Jul 23, 6:15AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company"
announced today, following its announcement dated July 1, 2014 (the "Previous Announcement" , that following the Court's approval the transactions contemplated by the settlement between the Company and Bank Leumi Le Israel B.M. ("Bank Leumi" have been consummated. Under the settlement, Bank Leumi received ownership of all marketable securities held in the Company's accounts at Bank Leumi having a fair value of approximately NIS 8.7 million (based on their quoted market price). The Company's net debt (after offset of the aforementioned marketable securities) to Bank Leumi in the amount of approximately NIS 38 million was cancelled in exchange for 7,404,119 ordinary shares, NIS 6,507,666 aggregate principal amount of Series G notes and NIS 3,166,678 aggregate principal amount of Series H notes of the Company. The balance of 1,686,003 ordinary shares, NIS 1,481,870 aggregate principal amount of Series G notes and NIS 721,089 aggregate principal amount of Series H notes of the Company retained in trust will be cancelled. As described in the Previous Announcement, the Settlement also includes a mutual waiver of claims by the Company and Bank Leumi. The Company's Subsidiary, Plaza Centers N.V., Announces Effectivness Of Debt Restructuring Plan
PR Newswire - Mon Jul 21, 2:06PM CDT
Elbit Imaging Ltd. ("EI" or the "Company"
(TASE, NASDAQ: EMITF) announced today further to the Company's announcements made on March 27, 2014 and June 26, 2014, that its subsidiary, Plaza Centers N.V. (LSE: PLAZ, WSE: PLZ/PLAZACNTR) ("Plaza" , has announced that following the Dutch Court (the "Court" approving Plaza's restructuring plan (the "Plan" on July 9, 2014, Plaza has received confirmation that the decision of the Court has become irrevocable and, as a result, the date of July 18, 2014 is the "Effective Date" as defined in the Plan on which the Plan becomes binding and effective. As a consequence of the confirmation decision becoming final, Plaza's suspension of payment proceedings, which commenced on November 18, 2013, has today come to an end and Plaza has successfully emerged from the reorganization proceedings. Accordingly, the administrator appointed by the Court to manage the affairs of Plaza alongside its existing management is no longer in office and Plaza's management has resumed full control of the business. Elbit Imaging Ltd. Announces Election of New Board Members of Plaza Centers
PR Newswire - Sun Jul 13, 8:38AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company"
announced today, that Plaza Centers N.V. ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds directly and indirectly approximately 62.5% of the outstanding shares, announced following its Annual General Meeting held on July 8, 2014, that the following individuals shall be appointed to its board of directors with immediate effect: Mr. Ron Hadassi, Mr. David Dekel, Mr. Shlomi Kelsi, Mr. Yoav Kfir, Mr. Nadav Livni. The newly appointed directors of Plaza will join Messrs Marco Habib Wichers and Sarig Shalhav to form a board of directors comprising seven members. Elbit Imaging Ltd. Calls 2014 Annual Shareholders Meeting
PR Newswire - Thu Jul 10, 4:29PM CDT
Elbit Imaging Ltd. (NASDAQ: EMITF)
Elbit Imaging Ltd. Announces: Dutch Court Approves Debt Restructuring Plan of Plaza Centers
PR Newswire - Thu Jul 10, 11:31AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company"
announced today, following its announcement dated June 26, 2014, that Plaza Centers N.V. ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds directly and indirectly approximately 62.5% of the outstanding shares, and following the confirmation hearing held yesterday, that the Dutch Court has confirmed Plaza's restructuring plan (the "Plan" . This follows Plaza receiving approval from 92% of creditors voting in favor of the Plan. Elbit Imaging's subsidiary signs sale agreement of PPHE Hotel Group's shares for USD10.2m
M2 - Mon Jul 07, 7:29AM CDT
Elbit Imaging Ltd (TASE:EMITF) (NASDAQ:EMITF) revealed on Friday that its wholly owned subsidiary signed into a transaction for the sale of 1.7m shares of PPHE Hotel Group (LSE
PH), for a net consideration of USD10.2m. 
